2021
DOI: 10.1016/j.ejogrb.2021.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Stage of ovarian cancer at diagnosis. Does presentation as an emergency make a difference?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 9 publications
1
2
0
Order By: Relevance
“…It is worth noting that clear cell cancer constitutes a larger percentage of ovarian cancers in East Asia and have a poorer prognosis compared to serous cancers [ 19 , 32 ]. Our study was concordant with previous ones [ 23 , 33 ]. In our study, there was also difference in histological subtypes between older patients and younger groups.…”
Section: Discussionsupporting
confidence: 94%
“…It is worth noting that clear cell cancer constitutes a larger percentage of ovarian cancers in East Asia and have a poorer prognosis compared to serous cancers [ 19 , 32 ]. Our study was concordant with previous ones [ 23 , 33 ]. In our study, there was also difference in histological subtypes between older patients and younger groups.…”
Section: Discussionsupporting
confidence: 94%
“…Japan, the United States, and Europe showed a similar trend in five-year RS [31]. Older women are more likely to have advanced ovarian cancer at the time of initial diagnosis and have a greater proportion of poorly diagnosed histological subtypes than younger women [32,33] In addition, younger patients often have more aggressive intentions toward treatment than elderly patients. Compared with young ovarian cancer patients receiving more combination treatment, elderly patients are more inclined to monotherapy, which also affects their survival [34].…”
Section: Discussionmentioning
confidence: 86%
“…In the current study, ovarian cancer was selected as a case study because it affects women of similar age groups as breast and cervical cancers (CRUK, 2021b ) and has the poorest prognosis among the gynaecological cancers (ONS, 2019a ). Despite this, symptom awareness for ovarian cancer is low (Low et al, 2013 ; Reid et al, 2021 ), and it has high mortality rate due to late diagnosis as outcomes are strongly linked with stage at presentation (Athey et al, 2021 ; ONS, 2019b ). Although ovarian cancer does not have a screening programme (Menon et al, 2021 ), it is important to increase ovarian cancer symptom awareness to improve help‐seeking behaviour for early diagnosis.…”
Section: Introductionmentioning
confidence: 99%